Enzytotal Tablet is a combination pharmaceutical formulation containing Bromelain (90 mg), Trypsin (48 mg), and Rutoside (100 mg), designed to provide anti-inflammatory, proteolytic, and vascular protective effects. Bromelain, a proteolytic enzyme derived from pineapple stems, facilitates the breakdown of proteins and exhibits significant anti-inflammatory and analgesic properties, making it effective in reducing edema and promoting tissue repair. Trypsin, a serine protease enzyme, enhances the proteolytic activity, aiding in the degradation of necrotic tissue and fibrin, thereby supporting wound healing and reducing inflammation. Rutoside, a bioflavonoid, contributes to vascular health by strengthening capillary walls, reducing capillary permeability, and exhibiting antioxidant effects that mitigate oxidative stress. The synergistic action of these active ingredients makes Enzytotal Tablet suitable for managing conditions characterized by inflammation, edema, and impaired microcirculation, such as post-traumatic swelling, postoperative inflammation, and chronic venous insufficiency. It is typically prescribed as an adjunct to conventional therapy to accelerate recovery and improve tissue repair processes. Enzytotal should be used under medical supervision, considering contraindications such as hypersensitivity to any component, bleeding disorders, or concurrent anticoagulant therapy. Adherence to recommended dosage and monitoring for adverse reactions is essential to ensure therapeutic efficacy and safety.